AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
来源：CNBC发布于 2026-10-05
AstraZeneca CEO Pascal Soriot told CNBC that Summit Therapeutics' lead drug could help power next-generation cancer combinations that could be the "future of cancer care." Soriot spoke exclusively wit...
相关标的：AZN
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。